Katarzyna Bilinska

Katarzyna Bilinska

Auto-generated profile, based on publicly available information

Katarzyna Bilinska

Department of Molecular Cell Genetics, L. Rydygier Collegium Medicum, Nicolaus Copernicus University, uI. Curie Sklodowskiej 9, 85-94 Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2020 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
KBKatarzyna Bilinska
Katarzyna Bilinska
PJPatrycja Jakubowska
Patrycja Jakubowska
CBChristopher S von Bartheld
Christopher S von Bartheld
RBRafał Butowt
Rafał Butowt


12 September 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MJMagdalena Jazurek-Ciesiołka
Magdalena Jazurek-Ciesiołka
ACAdam Ciesiolka
Adam Ciesiolka
JSJulia Starega-Roslan
Julia Starega-Roslan
KBKatarzyna Bilinska
Katarzyna Bilinska
WKWlodzimierz J. Krzyzosiak
Wlodzimierz J. Krzyzosiak
RNA–protein complexes play a central role in the regulation of fundamental cellular processes, such as mRNA splicing, localization, translation and degradation. The misregulation of these interactions can cause a variety of human diseases, including cancer and neurodegenerative disorders. Recently, many strategies have been developed to comprehensively analyze these complex and highly dynamic RNA–protein networks. Extensive efforts have been made to purify in vivo-assembled RNA–protein complexes. In this review, we focused on commonly used RNA-centric approaches that involve mass spectrometry, which are powerful tools for identifying proteins bound to a given RNA. We present various RNA capture strategies that primarily depend on whether the RNA of interest is modified. Moreover, we briefly discuss the advantages and limitations of in vitro and in vivo approaches. Furthermore, we describe recent advances in quantitative proteomics as well as the methods that are most commonly used to validate robust mass spectrometry data. Finally, we present approaches that have successfully identified expanded repeat-binding proteins, which present abnormal RNA–protein interactions that result in the development of many neurological diseases.

1 April 2026
Verified
Book Chapter
Closed access
APArnold Pabian
Arnold Pabian
EGElwira Gross Gołacka
Elwira Gross Gołacka
Barbara PabianBarbara Pabian
Barbara Pabian
KBKatarzyna Bilińska
Katarzyna Bilińska

19 September 2018 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
KBKatarzyna Bilińska
Katarzyna Bilińska
PJPatrycja Jakubowska
Patrycja Jakubowska
AWAgnieszka Woźniak
Agnieszka Woźniak
RBRafał Butowt
Rafał Butowt